Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors

Compounds for treating disorders sensitive to serotoninergic regulation controlled by the 5-HT1A receptors

US Patent 10562853 · Granted Feb 18, 2020

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for treating movement disorders with befiradol2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2025
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2024
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudd2024
Use of serotonin 5-HT1A receptor agonists to treat diseases associated with sudd2024
Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of2021
Use of selective serotonin 5-HT1A receptor agonists for treating side-effects of2021
Method for treating movement disorders with befiradol2021
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021
Indole and benzimidazole derivatives as dual 5-HT2A and 5-HT6 receptor antagonis2021